Summary
A POPULAR cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.
Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.See the full content of this document
Extract
Trees Could Hold the Key to Cheaper Drug
Scientists beh...
See the full content of this document
Sponsored links
